Operating income before deduction of amortization: cytekbio.com (CTKB)

Brandmark of Cytek Biosciences Inc (CTKB)

Cytek Biosciences, Inc. (CTKB) leads in spectral cell analysis thanks to its proprietary software. Production relies on external contractors for module assembly and logistics. Stable cash flow from instrument sales fully funds research and development. Total EBITDA for the period on this chart demonstrates real profitability, where 0.00 characterizes this operating profit valuation parameter.

Profit before payment of interest, taxes and amortization: Cytek Biosciences, Inc. (CTKB) for 11/23/2025 - 11/10/2026

Cytek Biosciences - analytical breakdowns and key metrics (CTKB)

- market value and analyst target forecast:
Market Price Cytek Corp|CTKB - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Cytek Biosciences|CTKB - Enterprise Value
- balance sheet equity data:
Net Assets per Share Cytek Biosciences|CTKB - Company Book Value|Market Capitalization to Book Value cytekbio.com|CTKB - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Cytek Biosciences, Inc.|CTKB - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Cytek Biosciences Inc|CTKB - Company Total Debt|Debt to Book Capital Cytek Biosciences|CTKB - Company Long-Term Debts|Short-Term Debt Cytek Biosciences|Quick Ratio cytekbio.com
- company profitability and valuation multiples indicators:
CTKB - Net Income|Expected Net Income Cytek Biosciences, Inc.|CTKB - P/E Multiple|Future Price to Earnings cytekbio.com|CTKB - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Cytek Biosciences|CTKB - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Cytek Biosciences|CTKB - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months cytekbio.com|CTKB - Earnings growth in current year|Expected earnings per share growth for next year Cytek Biosciences, Inc.
Fundamental company valuation:Cytek Corp CTKB
Mass-produced product of Cytek Biosciences, Inc.

Investors utilize asset filtering based on free cash flow to weed out illiquid companies. This metric measures operational efficiency by excluding non-cash depreciation charges and accounting adjustments. For Cytek Biosciences, Inc. (CTKB), this reflects the ability to generate cash while covering costs for specialized medical logistics and system calibration. Profit growth confirms market expansion. By analyzing the trend of gross operating profit before wear and tear, one can assess the risk of capital stagnation.

Who Cytek Biosciences, Inc. competes with

Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit EBITDA SHC|Operating profit before deduction of amortization quidel.com QDEL|OPKO Health - Operating profit before deduction of amortization|CareDx Corp (CDNA) - Profit before interest, taxes and amortization|MRVI: Operating profit before deduction of amortization|Fulgent - Company profit before taxes, interest and amortization|LAB: Operating profit EBITDA|Profit before interest, taxes and amortization orasure.com (OSUR)|Profit before payment of interest, taxes and amortization Exagen Inc|Operating profit EBITDA MDxHealth S.A.|Operating profit before deduction of amortization LUCD (Lucid Diagnostics Inc)|PRE (prenetics.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC - Profit before payment of interest, taxes and amortization|ProPhase Labs - Operating profit EBITDA|Operating income before deduction of amortization Ainos Inc AIMD|Co-Diagnostics Corp (CODX) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Heart Test Labs (HSCS)|Profit before payment of interest, taxes and amortization Biomerica, Inc.|Cardio Diagnostics Holdings, Inc. (CDIO) - Operating income before deduction of amortization|Operating profit EBITDA ONCO|Operating profit before deduction of amortization Virax Biolabs Group Limited VRAX|Operating profit EBITDA BJDX (Bluejay)|Operating income before deduction of amortization Aspira Women's Health Inc (AWH)|Accelerate Diagnostics - Operating profit EBITDA|Profit before interest, taxes and amortization Centogene|enzo.com (ENZ) - Profit before payment of interest, taxes and amortization|Operating profit before amortization FRES|GENE (Genetic Technologies Ltd) - Operating profit EBITDA|Operating profit before deduction of amortization 23andMe Inc (ME)|Operating profit EBITDA PMD